Evidence map›Paper›PMID 19190341›Full record

ArticleCancer research2009

Correlation analysis between single-nucleotide polymorphism and expression arrays in gliomas identifies potentially relevant target genes.

Yuri Kotliarov, Svetlana Kotliarova, Nurdina Charong, Aiguo Li, Jennifer Walling, Elisa Aquilanti, Susie Ahn, Mary Ellen Steed, Qin Su, Angela Center and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Cancer research, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 33 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Atrazine exposure elicits copy number alterations in the zebrafish genome.Comparative biochemistry and physiology. Toxicology & pharmacology : CBP · 2017
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Heme oxygenase-1 expression in human gliomas and its correlation with poor prognosis in patients with astrocytoma.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2014
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Yuri KotliarovNeuro-Oncology Branch, National Cancer Institute, NIH, Bethesda, Maryland, USA.
Svetlana Kotliarova
Nurdina Charong
Aiguo Li
Jennifer Walling
Elisa Aquilanti
Susie Ahn
Mary Ellen Steed
Qin Su
Angela Center
Jean C Zenklusen
Howard A Fine
National Cancer Institute · US

Funding

Identifying New Glioma-Associated Tumor Suppressors and OncogenesZIABC011101 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI GRESS, RONALD · 2009 to 2014
$3.3M
Exploring the Therapeutic Potential of Stem Cell Biology in GliomasZIABC010839 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI GRESS, RONALD · 2009 to 2014
$3.1M
The Role of miRNAs in Glioma Stem Cell and Glioma BiologyZIABC011102 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI FINE, HOWARD · 2009 to 2012
$2.9M
SCF as a Novel CNS and Glioma-Derived Angiogenic Factor and SC Chemotaxic FactorZIABC011100 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI FINE, HOWARD · 2009 to 2012
$2.7M
Elucidation and Exploitation of GSK3 as a Novel Glioma Therapeutic TargetZIABC010840 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI FINE, HOWARD · 2009 to 2012
$2.4M
Intramural NIH HHS Z99 CA999999
6 · The paper itself

Abstract

Primary brain tumors are a major cause of cancer mortality in the United States. Therapy for gliomas, the most common type of primary brain tumors, remains suboptimal. The development of improved therapeutics will require greater knowledge of the biology of gliomas at both the genomic and transcriptional levels. We have previously reported whole genome profiling of chromosome copy number alterations (CNA) in gliomas, and now present our findings on how those changes may affect transcription of genes that may be involved in tumor induction and progression. By calculating correlation values of mRNA expression versus DNA copy number average in a moving window around a given RNA probe set, biologically relevant information can be gained that is obscured by the analysis of a single data type. Correlation coefficients ranged from -0.6 to 0.7, highly significant when compared with previous studies. Most correlated genes are located on chromosomes 1, 7, 9, 10, 13, 14, 19, 20, and 22, chromosomes known to have genomic alterations in gliomas. Additionally, we were able to identify CNAs whose gene expression correlation suggests possible epigenetic regulation. This analysis revealed a number of interesting candidates such as CXCL12, PTER, and LRRN6C, among others. The results have been verified using real-time PCR and methylation sequencing assays. These data will further help differentiate genes involved in the induction and/or maintenance of the tumorigenic process from those that are mere passenger mutations, thereby enriching for a population of potentially new therapeutic molecular targets.

Indexed as

AdultBrain NeoplasmsChildDNA MethylationDNA, NeoplasmGliomaHumansLoss of HeterozygosityMutationNeoplasm ProteinsNerve Tissue ProteinsNucleic Acid HybridizationPolymorphism, Single NucleotidePromoter Regions, GeneticReverse Transcriptase Polymerase Chain ReactionDNA, NeoplasmNeoplasm ProteinsNerve Tissue Proteins

Identifiers

PMID19190341
PMCPMC2644341
OpenAlexW1997733964

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.